C4 Therapeutics, Inc. (CCCC) Revenue 2021–2025
C4 Therapeutics, Inc. (CCCC) annual revenue history from SEC filings — each fiscal year as reported, with year-over-year change.
$35.9MFY2025 · since FY2021: $45.8M → $35.9M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $35.9M | +1.0% |
| FY2024 | $35.6M | +71.4% |
| FY2023 | $20.8M | -33.3% |
| FY2022 | $31.1M | -32.1% |
| FY2021 | $45.8M | — |
Source: SEC XBRL filings · For reference only · Not investment advice